{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:11:20Z","timestamp":1760145080929,"version":"3.41.2"},"reference-count":41,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T00:00:00Z","timestamp":1509062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Science Reports"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Our aim is to identify important attributes of major diseases that shape how they are perceived by the public.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and Results<\/jats:title><jats:p>Four focus groups among members of the public were recruited, in March and October 2016, and used semistructured discussion to explore important attributes of cancer, heart disease, stroke, dementia, mental illness, and infectious disease. Common themes were identified by using inductive thematic analysis.<\/jats:p><jats:p>Five themes were identified: fear, impact on family and friends, hope, detection, and prevention. Fear of cancer includes not only fear of death but also of aggressive treatments. Loss of dignity is feared in dementia, while infectious disease raises fear of uncontrollable \u201cplague\u201d; in contrast, people with mental illness may themselves be seen as a potential threat. The impact of cancer and its treatment on family and friends was described as intense and all\u2010consuming, even for those not involved directly in caring; with dementia and stroke, the family impact is taking on care, including funding, over the long term with little expectation of improvement. Hope is a major theme in cancer and stroke recovery, linked with the need to take action, often expressed in aggressive language of \u201cfighting,\u201d but seen as futile in dementia. Detection difficulties for \u201csilent\u201d cancers mean that real treatment opportunities are missed; cardiovascular and infection risk, however, are seen as easy to identify and act on, whereas mental illness and dementia are seen as poorly diagnosed and with limited treatment options. Prevention awareness is high for cardiovascular disease and infection, lower for cancer, and limited for dementia and mental health.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although themes overlap across diseases, the specific concerns are different and each condition has a unique profile. Quantifying the relative importance of these themes could allow their incorporation in decision\u2010making, not only when they occur as a named disease but also in any relevant condition.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hsr2.16","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T13:06:39Z","timestamp":1509109599000},"source":"Crossref","is-referenced-by-count":3,"title":["Cancer as the \u201cperfect storm\u201d? A qualitative study of public attitudes to health conditions"],"prefix":"10.1002","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6382-1795","authenticated-orcid":false,"given":"Liz","family":"Morrell","sequence":"first","affiliation":[{"name":"Oxford\u2010UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), Radcliffe Department of Medicine University of Oxford  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne Sayuri","family":"Ii","sequence":"additional","affiliation":[{"name":"Oxford\u2010UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), Radcliffe Department of Medicine University of Oxford  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Wordsworth","sequence":"additional","affiliation":[{"name":"Health Economics Research Centre, Nuffield Department of Population Health University of Oxford  Oxford UK"},{"name":"Oxford NIHR Biomedical Research Centre University of Oxford  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Wilson","sequence":"additional","affiliation":[{"name":"National Cancer Research Institute Consumer Forum  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Rees","sequence":"additional","affiliation":[{"name":"Health Experiences Institute, Nuffield Department of Primary Care Health Sciences University of Oxford  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Barker","sequence":"additional","affiliation":[{"name":"Oxford\u2010UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), Radcliffe Department of Medicine University of Oxford  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,10,27]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpo.2016.09.007"},{"key":"e_1_2_7_3_1","unstructured":"MukherjeeS.The Emperor of All Maladies. Fourth Estate Harper Collins 2011."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005434"},{"key":"e_1_2_7_5_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/tcbh\/2.2.137","article-title":"Cancer, cancerphobia, and culture: reflections on attitudes in the United States and Great Britain","volume":"2","author":"Patterson JT","year":"1991","journal-title":"Twentieth Century Bntish History."},{"key":"e_1_2_7_6_1","unstructured":"BoseleyS.Breast cancer drug rejected for NHS use on cost\u2010benefit grounds. The Guardian.https:\/\/www.theguardian.com\/society\/2016\/dec\/29\/breast\u2010cancer\u2010drug\u2010kadcyla\u2010rejected\u2010for\u2010nhs\u2010use\u2010on\u2010cost\u2010benefit\u2010grounds;2016."},{"key":"e_1_2_7_7_1","unstructured":"Breast Cancer Now. Keep Kadcyla.http:\/\/breastcancernow.org\/get\u2010involved\/campaign\u2010with\u2010us\/our\u2010other\u2010work\/previous\u2010campaigns\/keep\u2010kadcyla;2017."},{"key":"e_1_2_7_8_1","unstructured":"GillA.AA Gill: \u201cMore life with your kids more life with your friends more life spent on earth\u2014but only if you pay\u201d. The Sunday Times.https:\/\/www.thetimes.co.uk\/magazine\/the\u2010sunday\u2010times\u2010magazine\/more\u2010life\u2010with\u2010your\u2010kids\u2010more\u2010life\u2010with\u2010your\u2010friends\u2010more\u2010life\u2010spent\u2010on\u2010earth\u2010but\u2010only\u2010if\u2010you\u2010pay\u2010d7lwpht3j?shareToken=26ba6b281d3f84f5012acb27d51932f6;2016."},{"key":"e_1_2_7_9_1","unstructured":"Roy Castle Lung Cancer Foundation. Calls for radical change after lung cancer drug axed.https:\/\/www.roycastle.org\/news\/calls\u2010for\u2010radical\u2010change\u2010after\u2010lung\u2010cancer\u2010drug\u2010axed;2015."},{"key":"e_1_2_7_10_1","unstructured":"Department of Health. Impact assessment of a proposal for a Cancer Drugs Fund.http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@en\/documents\/digitalasset\/dh_120930.pdf2010."},{"key":"e_1_2_7_11_1","doi-asserted-by":"crossref","unstructured":"MorrellL WordsworthS ReesS BarkerR.Does the public prefer health gain for cancer patients?A Systematic Review of Public Views on Cancer and its Characteristics. Pharmacoeconomics.2017.","DOI":"10.1007\/s40273-017-0511-7"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.2872"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2009.08.005"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2015.10.005"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03589.x"},{"key":"e_1_2_7_16_1","unstructured":"NICE.Guide to the methods of technology appraisal.http:\/\/www.nice.org.uk\/article\/pmg9\/resources\/non\u2010guidance\u2010guide\u2010to\u2010the\u2010methods\u2010of\u2010technology\u2010appraisal\u20102013\u2010pdf2013."},{"key":"e_1_2_7_17_1","unstructured":"NICE.Interim process and methods of the Highly Specialised Technologies programme.https:\/\/www.nice.org.uk\/Media\/Default\/About\/what\u2010we\u2010do\/NICE\u2010guidance\/NICE\u2010highly\u2010specialised\u2010technologies\u2010guidance\/HST\u2010interim\u2010methods\u2010process\u2010guide\u2010may\u201017.pdf;2017."},{"key":"e_1_2_7_18_1","unstructured":"Scottish Medicines Consortium.PACE (Patient & Clinician Engagement) overview document.http:\/\/www.scottishmedicines.org.uk\/files\/PACE\/PACE_Overview_Document_FINAL.pdf2014."},{"volume-title":"Care at the End of Life\u2014An Economic Perspective","year":"2016","author":"Shah K","key":"e_1_2_7_19_1"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X15619389"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X14547915"},{"key":"e_1_2_7_22_1","unstructured":"Office for National Statistics.Statistical bulletin: deaths registered in England and Wales (series DR): 2015.https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsregisteredinenglandandwalesseriesdr\/2015;2016."},{"key":"e_1_2_7_23_1","unstructured":"O'NeillJ.Tackling drug\u2010resistant infections globally: final report and recommendations.https:\/\/amr\u2010review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf;2016."},{"key":"e_1_2_7_24_1","unstructured":"Health Education England.Stepping forward to 2020\/21: mental health workforce plan for England.https:\/\/www.hee.nhs.uk\/our\u2010work\/person\u2010centred\u2010care\/mental\u2010health\/mental\u2010health\u2010workforce\u2010plan;2017."},{"key":"e_1_2_7_25_1","unstructured":"NICE.Cancer Drugs Fund.https:\/\/www.nice.org.uk\/about\/what\u2010we\u2010do\/our\u2010programmes\/nice\u2010guidance\/nice\u2010technology\u2010appraisal\u2010guidance\/cancer\u2010drugs\u2010fund;2016."},{"key":"e_1_2_7_26_1","unstructured":"NHS England.Cancer Drugs Fund (board paper).https:\/\/www.england.nhs.uk\/wp\u2010content\/uploads\/2016\/03\/item\u20104\u2010250216\u2010updated.pdf;2016."},{"key":"e_1_2_7_27_1","unstructured":"ABPI.ABPI comment on new Cancer Drugs Fund announcement.http:\/\/www.abpi.org.uk\/media\u2010centre\/newsreleases\/2016\/Pages\/170316.aspx;2016."},{"key":"e_1_2_7_28_1","unstructured":"Breakthrough Breast Cancer.Leading cancer charities call on PM to reform \u2018outdated\u2019 NICE drug appraisal process.http:\/\/breastcancernow.org\/news\u2010and\u2010blogs\/news\/leading\u2010cancer\u2010charities\u2010call\u2010on\u2010pm\u2010to\u2010reform\u2010outdated\u2010nice\u2010drug\u2010appraisal\u2010process;2016."},{"key":"e_1_2_7_29_1","unstructured":"GreenJJ ThorogoodN.Qualitative methods for health research.2009."},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"e_1_2_7_32_1","doi-asserted-by":"crossref","unstructured":"VrintenC McGregorLM HeinrichM vonWagnerC WallerJ WardleJ et al.What do people fear about cancer? A systematic review and meta\u2010synthesis of cancer fears in the general population. Psycho\u2010Oncology.2016.","DOI":"10.1002\/pon.4287"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0146167214557006"},{"key":"e_1_2_7_34_1","doi-asserted-by":"crossref","first-page":"e608","DOI":"10.3747\/co.20.1635","article-title":"Metaphors and malignancy: making sense of cancer","volume":"20","author":"Nicholas G","year":"2013","journal-title":"Curr Oncol."},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2014-000785"},{"key":"e_1_2_7_36_1","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0140-6736(14)60907-7","article-title":"The war on cancer: time for a new terminology","volume":"383","author":"Haines I","year":"2014","journal-title":"Lancet."},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-016-0769-1"},{"key":"e_1_2_7_38_1","unstructured":"WilsonA.Obama's tweet to John McCain about his diagnosis was the last thing cancer survivors wanted to see. The Independent.http:\/\/www.independent.co.uk\/voices\/john\u2010mccain\u2010brain\u2010cancer\u2010barack\u2010obama\u2010tweet\u2010donald\u2010trump\u2010war\u2010survivors\u2010a7851296.html;2017."},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5941"},{"key":"e_1_2_7_40_1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12913-017-2561-0","article-title":"Cancer drug funding decisions in Scotland: impact of new end\u2010of\u2010life, orphan and ultra\u2010orphan processes","volume":"17","author":"Morrell L","year":"2017","journal-title":"BMC Health Services Research."},{"key":"e_1_2_7_41_1","unstructured":"MontgomeryB.Review of access to new medicines\u2014independent review.http:\/\/www.gov.scot\/Resource\/0051\/00511595.pdf;2016."},{"key":"e_1_2_7_42_1","unstructured":"The Parliamentary Office of Science and Technology.Value based assessment of drugs. researchbriefings.files.parliament.uk\/documents\/POST\u2010PN\u2010487\/POST\u2010PN\u2010487.pdf;2015."}],"container-title":["Health Science Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhsr2.16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T23:24:32Z","timestamp":1695770672000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hsr2.16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1002\/hsr2.16"],"URL":"https:\/\/doi.org\/10.1002\/hsr2.16","archive":["Portico"],"relation":{},"ISSN":["2398-8835","2398-8835"],"issn-type":[{"type":"print","value":"2398-8835"},{"type":"electronic","value":"2398-8835"}],"subject":[],"published":{"date-parts":[[2017,10,27]]},"article-number":"e16"}}